{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:13:14Z","timestamp":1789049594218,"version":"build-2803163510"},"reference-count":41,"publisher":"Bioscientifica","issue":"9","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clinically inapparent node metastases, requiring neck dissection in addition to thyroidectomy, pose a diagnostic challenge in patients with medullary thyroid cancer (MTC). Although desmoplasia negativity has emerged as a powerful marker of node-negative disease, its clinical utility in hereditary MTC remains ill-defined. This cross-sectional investigation employed multivariable logistic regression on, and stratification of clinical variables by, nodal status of 124 RET carriers with MTC who underwent initial total thyroidectomy with at least central neck dissection between 2000 and 2025 at a tertiary center. Unlike tumor size, grade, laterality, index status, and sex, only desmoplasia (&amp;gt;10% vs \u22645%), basal serum calcitonin (&amp;gt;500 pg\/mL &amp;gt;&amp;gt; 101\u2013500 pg\/mL vs \u2264100 pg\/mL), and RET category (highest (p.Met918Thr) vs any other) were independently associated with node metastases. In unilateral MTC, desmoplasia \u22645% was always associated with freedom from node metastases (0 of 15 patients), whereas tumor size \u22645 mm and basal serum calcitonin \u2264100 pg\/mL were associated with node metastases in 4 (18%) of 22 patients and 4 (15%) of 26 patients, respectively. In bilateral MTC, none of the above thresholds were sufficiently discriminatory, suggesting metastatic cross-contamination by the contralateral MTC. In unilateral MTC with desmoplasia \u22645%, node metastases were always absent, regardless of whether basal calcitonin levels were \u2264100 (based on 13 patients) or &amp;gt;100 pg\/mL (based on 2 patients). This comprehensive proof-of-concept study demonstrates that RET carriers with desmoplasia-negative unilateral MTC may forgo node dissection at specialist centers, similarly to what has been proposed for patients with desmoplasia-negative sporadic MTC.<\/jats:p>","DOI":"10.1530\/erc-26-0148","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:15:37Z","timestamp":1786364137000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Forgoing node dissection for desmoplasia-negative hereditary medullary thyroid cancer"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-079X","authenticated-orcid":true,"given":"Andreas","family":"Machens","sequence":"first","affiliation":[{"name":"Department of Visceral, Vascular and Endocrine Surgery 1 , Martin Luther University Halle-Wittenberg, ,","place":["Halle (Saale), Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bensch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Martin Luther University Halle-Wittenberg 2 , ,","place":["Halle (Saale), Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1807-5575","authenticated-orcid":true,"given":"Claudia","family":"Wickenhauser","sequence":"additional","affiliation":[{"name":"Department of Pathology, Martin Luther University Halle-Wittenberg 2 , ,","place":["Halle (Saale), Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3169-9251","authenticated-orcid":true,"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[{"name":"Department of Visceral, Vascular and Endocrine Surgery 1 , Martin Luther University Halle-Wittenberg, ,","place":["Halle (Saale), Germany"]},{"name":"Department of General, Visceral and Transplantation Surgery, Section of Endocrine Surgery, University of Duisburg-Essen 3 , ,","place":["Essen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-1950","authenticated-orcid":true,"given":"Kerstin","family":"Lorenz","sequence":"additional","affiliation":[{"name":"Department of Visceral, Vascular and Endocrine Surgery 1 , Martin Luther University Halle-Wittenberg, ,","place":["Halle (Saale), Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2026091009320129300_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"American Thyroid Association guidelines task force on medullary thyroid carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"2026091009320129300_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2021.09.012","article-title":"Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma","volume":"158","author":"Shankar","year":"2021","journal-title":"Eur J Cancer"},{"key":"2026091009320129300_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","article-title":"LIBRETTO-531 trial investigators. Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer","volume":"389","author":"Hadoux","year":"2023","journal-title":"N Engl J Med"},{"key":"2026091009320129300_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/thy.2024.0495","article-title":"Efficacy and safety of selective RET inhibitors in patients with advanced hereditary medullary thyroid carcinoma","volume":"35","author":"Hamidi","year":"2025","journal-title":"Thyroid"},{"key":"2026091009320129300_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.2024.0076","article-title":"Anatomical patterns of nodal spread in unilateral papillary and medullary thyroid cancer","volume":"34","author":"Machens","year":"2024","journal-title":"Thyroid"},{"key":"2026091009320129300_bib6","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0038","article-title":"Genotype-specific development of MEN 2 constituent components in 683 RET carriers","volume":"31","author":"Machens","year":"2024","journal-title":"Endocr Relat Cancer"},{"key":"2026091009320129300_bib7","doi-asserted-by":"crossref","first-page":"e3582","DOI":"10.1210\/clinem\/dgab326","article-title":"Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma","volume":"106","author":"Raue","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091009320129300_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1089\/thy.2019.0579","article-title":"Structural doubling time predicts overall survival in patients with medullary thyroid cancer in patients with rapidly progressive metastatic medullary thyroid cancer treated with molecular targeted therapies","volume":"30","author":"Yeh","year":"2020","journal-title":"Thyroid"},{"key":"2026091009320129300_bib9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s40618-026-02846-y","article-title":"Comparison of pre-operative calcitonin, FNAC, and ultrasound risk stratification systems in patients with medullary thyroid carcinoma","volume":"49","author":"Matrone","year":"2026","journal-title":"J Endocrinol Investig"},{"key":"2026091009320129300_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1245\/s10434-012-2589-7","article-title":"Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening","volume":"20","author":"Morris","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2026091009320129300_bib11","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1210\/jc.2009-2368","article-title":"Biomarker-based risk stratification for previously untreated medullary thyroid cancer","volume":"95","author":"Machens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091009320129300_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109756","article-title":"Incidence and distribution of neck node metastases in hereditary vs. sporadic medullary thyroid cancer at basal calcitonin serum levels \u2264100 pg\/mL: 30-year experience","volume":"51","author":"Machens","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"2026091009320129300_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00268-005-0391-4","article-title":"Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative \u2018marker\u2019 for lymph node metastases","volume":"30","author":"Scheuba","year":"2006","journal-title":"World J Surg"},{"key":"2026091009320129300_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2559.2008.03002.x","article-title":"Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential","volume":"52","author":"Koperek","year":"2008","journal-title":"Histopathology"},{"key":"2026091009320129300_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00428-018-2303-7","article-title":"Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement","volume":"472","author":"Aubert","year":"2018","journal-title":"Virchows Arch"},{"key":"2026091009320129300_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.surg.2021.07.035","article-title":"Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer","volume":"171","author":"Machens","year":"2022","journal-title":"Surgery"},{"key":"2026091009320129300_bib17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.surg.2023.09.003","article-title":"Sporadic noninvasive medullary thyroid neoplasm: a desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy","volume":"174","author":"Dralle","year":"2023","journal-title":"Surgery"},{"key":"2026091009320129300_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/bjs\/znad172","article-title":"Desmoplastic reaction in medullary thyroid carcinoma predicts presence of lymph node metastasis","volume":"110","author":"G\u00f3mez-Ram\u00edrez","year":"2023","journal-title":"Br J Surg"},{"key":"2026091009320129300_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.05.063","article-title":"Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?","volume":"177","author":"Procopio","year":"2025","journal-title":"Surgery"},{"key":"2026091009320129300_bib20","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/wjs.70282","article-title":"Can desmoplastic stromal reaction guide the extent of lymph node surgery in sporadic medullary thyroid carcinoma?","volume":"50","author":"Matlim Ozel","year":"2026","journal-title":"World J Surg"},{"key":"2026091009320129300_bib21","doi-asserted-by":"crossref","first-page":"K21","DOI":"10.1093\/ejendo\/lvad177","article-title":"Comparing nodal with primary tumor desmoplasia uncovers metastatic patterns in multiple endocrine neoplasia 2B","volume":"190","author":"Machens","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026091009320129300_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00423-013-1057-6","article-title":"German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors","volume":"398","author":"Dralle","year":"2013","journal-title":"Langenbecks Arch Surg"},{"key":"2026091009320129300_bib23","first-page":"267","article-title":"Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin","volume":"114","author":"Bieglmayer","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"2026091009320129300_bib24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1515\/CCLM.2007.124","article-title":"Measurement of calcitonin by immunoassay analyzers","volume":"45","author":"Bieglmayer","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"2026091009320129300_bib25","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1515\/cclm-2015-0587","article-title":"Comparison of the Elecsys calcitonin assay with the immulite 1000 assay. Describing one case with heterophilic antibody interference","volume":"54","author":"Bories","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2026091009320129300_bib26","first-page":"174","volume-title":"Endocrine and Neuroendocrine Tumours: WHO Classification of Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2025","edition":"5th edn"},{"key":"2026091009320129300_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.21.01329","article-title":"International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma","volume":"40","author":"Xu","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026091009320129300_bib28","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1530\/ERC-17-0303","article-title":"RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2)","volume":"25","author":"Castellone","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026091009320129300_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"2026091009320129300_bib30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/bjs\/znab106","article-title":"Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels","volume":"108","author":"Fanget","year":"2021","journal-title":"Br J Surg"},{"key":"2026091009320129300_bib31","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1089\/thy.2019.0785","article-title":"Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays?","volume":"30","author":"Niederle","year":"2020","journal-title":"Thyroid"},{"key":"2026091009320129300_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.oraloncology.2013.03.443","article-title":"Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging","volume":"49","author":"Tuttle","year":"2013","journal-title":"Oral Oncol"},{"key":"2026091009320129300_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2014.0277","article-title":"Response to initial therapy predicts clinical outcomes in medullary thyroid cancer","volume":"25","author":"Lindsey","year":"2015","journal-title":"Thyroid"},{"key":"2026091009320129300_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/thy.2022.0295","article-title":"An undetectable postoperative calcitonin level is associated with long-term disease-free survival in medullary thyroid carcinoma: results of a retrospective cohort study","volume":"33","author":"Duval","year":"2023","journal-title":"Thyroid"},{"key":"2026091009320129300_bib35","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2017-00317","article-title":"Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness","volume":"102","author":"Voss","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091009320129300_bib36","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2019-00516","article-title":"Long-term outcomes and aggressiveness of hereditary medullary thyroid carcinoma: 40 years of experience at one center","volume":"104","author":"Raue","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091009320129300_bib37","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/jcm15041611","article-title":"Current evidence, selective indications, and the role of lymph-node assessment in intraoperative frozen section in thyroid cancer surgery: a literature review","volume":"15","author":"Scerrino","year":"2026","journal-title":"J Clin Med"},{"key":"2026091009320129300_bib38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ejso.2020.11.006","article-title":"Prophylactic neck surgery for second-generation multiple endocrine neoplasia type 2B","volume":"47","author":"Machens","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2026091009320129300_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.semdp.2025.150902","article-title":"The importance of frozen section analysis in head, neck, and endocrine pathology","volume":"42","author":"Darwish","year":"2025","journal-title":"Semin Diagn Pathol"},{"key":"2026091009320129300_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026091009320129300_bib41","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1210\/jc.2018-02102","article-title":"Fifty years after the first description, MEN 2B syndrome diagnosis is still late: descriptions of two recent cases","volume":"104","author":"Elisei","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0148\/523369\/erc-26-0148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0148\/523369\/erc-26-0148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:32:14Z","timestamp":1789047134000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/9\/e260148\/77972\/Forgoing-node-dissection-for-desmoplasia-negative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-26-0148","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"e260148"}}